Abstract:Rationale: The molecular mechanisms underlying the pathogenesis of systemic insulin resistance in type 2 diabetes remain elusive. Growth hormone receptor (GHR) deficiency has long been known to improved insulin sensitivity. However, whether hepatic GHR overexpression or activation is a cause of insulin resistance is still unknown. The aim of this study was to identify the new role of GHR in systemic insulin resistance and explore the underlying mechanism. Method: Different samples obtained from obese humans, ob/ob mice, db/db mice, high-fat diet (HFD)-fed mice and primary mouse hepatocytes were used to evaluate the correlations between GHR and metabolic disorders. Recombinant adeno-associated viruses encoding GHR and STAT5 and GHR knockout mice were used to investigate the roles of hepatic GHR in glucose homeostasis. Tissue H&E, Oil Red O and PAS staining were performed for histomorphological analysis. Gel filtration chromatography was employed for the separation of serum RBP4-TTR complexes. Plasmids (related to GHR, STAT5 and HIF1α), siRNA oligos (siGHR and siSTAT5), luciferase activity and ChIP assays were used to explore the potential mechanism of hepatic GHR. Results: Here, we found that hepatic GHR expression was elevated during metabolic disorder. Accordingly, hepatic GHR overexpression disrupted systemic glucose homeostasis by promoting gluconeogenesis and disturbing insulin responsiveness in the liver. Meanwhile, hepatic GHR overexpression promoted lipolysis in white adipose tissue and repressed glucose utilization in skeletal muscle by promoting the circulating level of RBP4, which contributed to impaired systemic insulin action. A mechanistic study revealed that hepatic GHR disrupted systemic insulin sensitivity by increasing RBP4 transcription by activating STAT5. Additionally, overexpression of hepatic GHR promoted TTR transcriptional levels by enhancing the expression of HIF1α, which not only increased the protein stability of RBP4 but also inhibited renal clearance of RBP4 in serum. Conclusions: Hepatic GHR overexpression and activation accelerated systemic insulin resistance by increasing hepatic RBP4 production and maintaining circulating RBP4 homeostasis. Our current study provides novel insights into the pathogenesis of type 2 diabetes and its associated metabolic complications.

Insulin induces insulin receptor degradation in the liver through EphB4

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

Effects of apolipoprotein E on regulating insulin sensitivity via regulating insulin receptor signalosome in caveolae

Egr‐1 Transcriptionally Activates Protein Phosphatase PTP1B to Facilitate Hyperinsulinemia‐induced Insulin Resistance in the Liver in Type 2 Diabetes

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.

Down-regulation of Hepatic HNF4alpha Gene Expression During Hyperinsulinemia Via SREBPs.

Egr-1 Decreases Adipocyte Insulin Sensitivity by Tilting Pi3k/Akt and Mapk Signal Balance in Mice

Insulin receptor isoform B is required for efficient proinsulin processing in pancreatic β cells

Molecular Mechanism of Insulin Resistance

An Early Response Transcription Factor, Egr-1, Enhances Insulin Resistance in Type 2 Diabetes with Chronic Hyperinsulinism

[The Expression of Insulin Signal Transduction Molecules and Islet Alpha Cell Insulin Resistance].

Inhibition of Obesity-Induced Hepatic ER Stress by Early Insulin Therapy in Obese Diabetic Rats

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2

Insulin Therapy Stimulates Lipid Synthesis and Improves Endocrine Functions of Adipocytes in Dietary Obese C57BL/6 Mice

Activation of the canonical ER stress IRE1-XBP1 pathway by insulin regulates glucose and lipid metabolism

Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4

Protein Phosphatase 4 (PP4) Functions As a Critical Regulator in Tumor Necrosis Factor (Tnf)-Α-induced Hepatic Insulin Resistance

Reduction of Ptp1b by Rnai Upregulates the Activity of Insulin Controlled Fatty Acid Synthase Promoter